Clinical Pathway for Evaluation/Treatment of Children
with Suspected Atopic Dermatitis
- Related Pathway
- Cellulitis/Abscess, ED and Inpatient
CHOP Formulary
- Front-line Ordering Clinician (FLOC), RN Team
- Assessment
Severity | Location | Age < 3 yrs Ointment covered by most insurance payers |
Age ≥ 3 yrs Ointment covered by most insurance payers |
---|---|---|---|
Mild | Face/Genitals | 2.5% Hydrocortisone base | 2.5% Hydrocortisone base |
Mild | Body | 2.5% Hydrocortisone base | 0.025% Triamcinolone acetonide |
Moderate | Face/Genitals | 0.025% Triamcinolone acetonide | 0.025% Triamcinolone acetonide |
Moderate | Body | 0.025% Triamcinolone acetonide | 0.1% Triamcinolone acetonide |
Severe | Face/Genitals | 0.025% Triamcinolone acetonide | 0.025% Triamcinolone acetonide |
Severe | Body | 0.1% Triamcinolone acetonide | 0.05% Fluocinonide |
- Always use Steroid Medication in ointment formulation, Recommended ointment covered by most insurance payers if child is already using applicable medication, refer to Steroid Potency Table
- CHOP Formulary
- Other Considerations
- Refractory Atopic Dermatitis
- AD Action Plan
Posted: October 2018
Revised: January 2023
Authors: K. Woo Castelo CRNP; M. Jen MD; C. Tucker MD; K. Gupta MD; J. Hart MD; E. Delgado MD;
L. Wilson RN; A. Verma MD; M. Perman MD; J. Treat MD
Revised: January 2023
Authors: K. Woo Castelo CRNP; M. Jen MD; C. Tucker MD; K. Gupta MD; J. Hart MD; E. Delgado MD;
L. Wilson RN; A. Verma MD; M. Perman MD; J. Treat MD
Evidence
- NICE Eczema Pathways
- Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers
- Food Allergy and Atopic Eczema
- How to: EASI Score
- View Evidence
Community Resources
Related CHOP Programs